Experimental study of ~(99)Tc-MDP in the treatment of different stages of osteopenia induced by glucocorticoid in animal models

MEI Xiaogang,GAO Kejia,XU Ming,YE Zhiwei,ZHOU Ruiming
2013-01-01
Abstract:Objective To explore the efficacy and value of 99Tc-MDP in the treatment of different stages of osteopenia induced by glucocorticoid in animal models.Methods Rabbit model with different statges of osteopenia were established using intramuscular injection of dexamethasone(DX).All the 49 rabbits were divided into 7 groups: the normal control group(Group A),the critical osteopenia in control group(Group B),the critical osteopenia therapy group(Group C),the osteopenia in control group(Group D),the osteopenia therapy group(Group E),the osteoporosis control group(Group F),and the osteoporosis therapy group(Group G).Rabbits in Group C,E,and G were treated with 99Tc-MDP for 16 weeks.Then the pathological histolody was observed.The bone mineral density,ROI,X-ray and CT scanning,BALP,and BGP were determined.A SPSS 13.0 software was used for variance analysis and t-test.Results The bone mineral density(the left femoral neck: F=31.038,L4: F=13.069,P<0.05),the ratio of bone imaging(the left femoral: F=36.045,L4: F=47.435,P<0.05) in Group B,D,and F were significantly different with those in Group A(T>2.179,P<0.05).The pathological results in Group A and B were normal.The trabeculae in Group D arranged irregularly and thin,while in Group F the trabeculae appeared irregular-arranged and sparse distribution and had fracture phenomenon.Analysis of results in treatment groups indicated that there was no statistical difference among Group C,E,and Group A(T<2.179,P>0.05),while significant difference between Group G and Group A was observed(P<0.05).The difference between groups before and after the treatment was significant(T>2.179,P<0.05).Pathology study showed that the trabecular distribution and arrangement in Group C and E was close to Group A.And the sparse trabeculae in Group G also improved.Conclusion 99Tc-MDP is effective in the treatment of different stages of osteopenia in animal models,especially for early bone loss(the critical osteopenia period).The treatment shows obvious effect in the early loss of bone calcium,which provides clinical reference for early detection and treatment of bone mass loss.
What problem does this paper attempt to address?